Lactose (India) Ltd.
BSE: 524202 | Sector: Health care |
NSE: N.A. | ISIN Code: INE058I01013 |
BSE 15:40 | 31 Jan | 49.20 |
0 (0.00%) |
OPEN
49.20 |
HIGH
49.20 |
LOW
47.20 |
NSE 05:30 | 01 Jan | Lactose (India) Ltd |
OPEN | 49.20 |
PREVIOUS CLOSE | 49.20 |
VOLUME | 73 |
52-Week high | 96.35 |
52-Week low | 44.55 |
P/E | 20.94 |
Mkt Cap.(Rs cr) | 62 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Lactose (India) Ltd. (LACTOSEINDIA) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 1037.25 | -13.65 | -1.30 | 15585.98 |
Dr Reddy's Labs | 4314.75 | -16.70 | -0.39 | 14405.20 |
Cipla | 1017.00 | -17.80 | -1.72 | 13091.79 |
Lupin | 741.05 | 6.65 | 0.91 | 11771.67 |
Aurobindo Pharma | 408.30 | -3.30 | -0.80 | 11287.14 |
Divi's Lab. | 3317.45 | -49.90 | -1.48 | 8879.82 |
Alkem Lab | 3003.40 | -4.00 | -0.13 | 8829.81 |
Glenmark Pharma. | 383.10 | 12.00 | 3.23 | 8141.58 |
Zydus Lifesci. | 430.75 | 2.85 | 0.67 | 7981.90 |
Torrent Pharma. | 1524.00 | -23.65 | -1.53 | 6742.32 |
Apollo Hospitals | 4255.55 | 17.25 | 0.41 | 6098.30 |
Ipca Labs. | 853.05 | -2.30 | -0.27 | 5399.36 |
Alembic Pharma | 539.10 | 1.80 | 0.34 | 5035.41 |
Abbott India | 20785.15 | -182.60 | -0.87 | 4919.27 |
Laurus Labs | 330.40 | -11.45 | -3.35 | 4707.04 |
Gland Pharma | 1302.00 | -7.95 | -0.61 | 4400.71 |
Granules India | 295.20 | 3.95 | 1.36 | 3238.44 |
Glaxosmi. Pharma | 1248.90 | -9.75 | -0.77 | 3217.51 |
Ajanta Pharma | 1210.00 | 2.10 | 0.17 | 3140.64 |
Piramal Pharma | 104.90 | 2.95 | 2.89 | 3094.95 |
Quick Links for Lactose (India):
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices